digoxin immune fab digifab logo DIGIFab

DIGIFab® Resources for Your Practice

digoxin-toxicity-expert-consensus-guidelines-image

The Royal College of Emergency Medicines and National Poisons Information Service Guideline on Antidote Availability¹

Recommendations for antidote stocking for emergency departments

  • DIGIFab® should be immediately available in the emergency department or any areas where poisoned patients are initially treated1
  • The recommended stock is 5 vials*
  • It is important that antidotes such as DIGIFab® are available in a timely fashion to ensure optimal patient care
View Guideline within
NPIS Antidotes

Recommendations for antidote stocking for emergency departments

  • DIGIFab® should be immediately available in the emergency department or any areas where poisoned patients are initially treated1
  • The recommended stock is 5 vials*
  • It is important that antidotes such as DIGIFab® are available in a timely fashion to ensure optimal patient care
View Guideline within NPIS Antidotes

Understanding Potentially Life-Threatening Digoxin Toxicity Video

Watch Video
Watch Video

Mechanism of Action of DIGIFab® Video

Watch Video
Watch Video

Recommended minimum stocking levels based on the amount required to initiate treatment for an adult patient in the emergency department and to continue treatment for
the first 24 hours. Higher stock levels may be required; individual departments should determine the amount stocked based on the epidemiology of poisoning presentations to their department.

References

  1. Royal College of Emergency Medicines and National Poisons Information Service Guideline on Antidote Availability for Emergency Departments. Guideline available from RCEM, at: https://rcem.ac.uk/clinical-guidelines/ Accessed December 2024.
  2. Levine MD, O’Connor A. Digitalis (cardiac glycoside) poisoning. UpToDate. Updated January 2020. https://www.uptodate.com/contents/digitalis-cardiac-glycoside-poisoning. Accessed December 2024.
  3. Data on file. BTG International Ltd.